Additionally, many tumor types with low degree of T-cell infiltration which respond poorly to immunotherapy such as pancreatic, colon, and prostate cancers upregulate additional immune suppressive mechanisms including TGF-β, MDSC, and mesenchymal features [36,37,38,39]. The gene discussed is TGFB1; the disease is prostate cancer.